Home › Galena Biopharma Receives New Coverage from Analysts at Oppenheimer
 

Keywords :   


Galena Biopharma Receives New Coverage from Analysts at Oppenheimer

2013-11-27 00:45:43| Biotech - Topix.net

The firm set an "outperform" rating and a $6.00 price target on the stock. Oppenheimer's price target suggests a potential upside of 63.49% from the stock's previous close.

Tags: coverage receives analysts oppenheimer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.06Atlantic Tropical Weather Outlook
15.06Eastern North Pacific Tropical Weather Outlook
15.06With Gratitude for a Job Well Done
15.06Weekly Recap: PPG, AkzoNobel, Hempel Top This Weeks Stories
15.06Atlantic Tropical Weather Outlook
15.06Eastern North Pacific Tropical Weather Outlook
15.06Atlantic Tropical Weather Outlook
15.06Eastern North Pacific Tropical Weather Outlook
More »